Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
17%
ALSO IN PPH
PPH
27
HOLDINGS
43%
ALSO IN XLV
SECTOR DRIFT (XLV minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.4% | 18.9% | 14.4% |
|
MERCK & CO. INC. | 5.3% | 9.7% | 5.3% |
|
JOHNSON & JOHNSON | 10.7% | 5.0% | 5.0% |
|
ABBVIE INC | 7.2% | 4.2% | 4.2% |
|
PFIZER INC | 2.8% | 4.9% | 2.8% |
XLV Overweight Relative to PPH
|
JOHNSON & JOHNSON | 5.7% |
|
UNITEDHEALTH GROUP INC | 4.7% |
|
AMGEN INC | 3.6% |
|
ABBOTT LABORATORIES | 3.5% |
|
GILEAD SCIENCES INC | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
ABBVIE INC | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
DANAHER CORP | 2.2% |
XLV Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -11.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.8% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.7% |
|
ELI LILLY & CO | -4.5% |
|
MERCK & CO. INC. | -4.4% |
 |
SANOFI-AVENTIS-ADR | -3.9% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |
|
CENCORA INC | -2.8% |
|
MCKESSON CORP | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |